Medullary Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Medullary Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients [Phase 2]
This update reports the completion of Bayer-sponsored Phase II trial evaluating sorafenib in Japanese patients with anaplastic or medullary …
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study [NA]
Pre-operative nodal staging of thyroid cancer evaluated with USPIO MRI in a preliminary study; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) [Phase 1, Phase 2]
Phase I/II trial evaluating vandetanib (ZD6474) plus bortezomib in adults with medullary thyroid carcinoma; study status TERMINATED with res…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib [Phase 1]
A Phase 1 study in healthy volunteers to assess whether omeprazole and ranitidine alter the pharmacokinetics of vandetanib, a therapy used f…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice
A Belgian registry study evaluating the use of vandetanib (Caprelsa) in current clinical practice for metastatic medullary thyroid carcinoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer [Phase 2]
A Phase 2 trial evaluating sunitinib malate for iodine-refractory recurrent or metastatic thyroid cancer has completed enrollment and posted…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 1]
Phase 1 clinical trial evaluating the combination of Cixutumumab, Everolimus, and Octreotide acetate in patients with advanced low- to inter…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating SOM230 alone or in combination with RAD001 for medullary thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Ponatinib for Advanced Medullary Thyroid Cancer [Phase 2]
A Phase 2 trial of ponatinib for advanced medullary thyroid carcinoma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-11-27Clinical Trial Update: To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer [Phase 4]
A Phase 4 trial comparing two doses of vandetanib in patients with advanced medullary thyroid carcinoma has completed. Results were posted o…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial results show vandetanib was evaluated for safety and tolerability in Japanese patients with unresectable locally ad…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluated Imatinib in combination with Dacarbazine and Capecitabine for medullary thyroid carcinoma.
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer [Phase 3]
Phase 3 trial update on cabozantinib (XL184) for advanced medullary thyroid cancer provides efficacy results.
-
CLINICAL_TRIALS trial_result · 2014-08-11Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer [Phase 2]
Phase 2 trial evaluating the histone deacetylase inhibitor suberoylanilide hydroxamic acid (vorinostat) in patients with metastatic and/or l…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial of tanespimycin in patients with inoperable locoregionally advanced or metastatic thyroid cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer [Phase 1, Phase 2]
The document discusses an ongoing evaluation of CASAD for diarrhea related to medullary thyroid carcinoma across Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer [Phase 2]
Phase 2 study results are reported for ZD6474 (vandetanib, ZACTIMA) as monotherapy in hereditary medullary thyroid carcinoma, with results p…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer [Phase 3]
Phase 3 trial comparing vandetanib (ZD6474) to placebo in medullary thyroid carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma [Phase 2]
A Phase II clinical trial evaluating a two-step radioimmunotherapy approach for medullary thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors [Phase 3]
This is a Phase 3 clinical trial update evaluating 123I‑MIBG scintigraphy for evaluating patients with suspected neuroendocrine tumors, incl…
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer [Phase 2]
A Phase 2 clinical trial evaluating 18F-DOPA PET imaging for medullary thyroid carcinoma has been terminated.